AVH AVITA Medical, Inc.

—Mkt Cap: —P/E: —

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is th…

Key Statistics

Company
Market Cap—
Enterprise Value105.32M USD
Revenue (TTM)52.27M USD
Gross Profit40.65M USD
Net Income (TTM)-33.58M USD
Revenue/Share2.52 AUD
Last Price—
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees226
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU000000AVH4
Valuation
P/E (Trailing)—
P/E (Forward)-11.67
PEG0.78
EV/EBITDA-4.65
EV/Revenue2.01
P/S7.61
P/B-2.88
EPS (TTM)-0.42
EPS (Forward)-0.32
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin82.13%
Oper. Margin-31.59%
EBITDA Margin-43.32%
Profit Margin-67.85%
ROE291.81%
ROA-86.16%
Growth
Revenue Growth17.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.56M USD
CapEx (TTM)1.20M USD
FCF Margin-17.65%
FCF Yield—
Net Debt25.81M USD
Net Debt/EBITDA-1.14
Balance Sheet
Debt/Equity-2.77
Current Ratio0.41
Quick Ratio0.31
Book Value/Sh-1.29 AUD
Cash/Share0.36 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split5:100
Split DateJun 24, 2020
Analyst Consensus
Rating—
Target (Mean)3.280 AUD
Target Range2.200 AUD – 3.720 AUD
# Analysts4
Ownership
Shares Out.154.63M
Float30.46M
Insiders0.18%
Institutions0.00%
Technical
SMA 502.972 AUD
SMA 2001.659 AUD
Beta1.99
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)249.61K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—